
Compass Therapeutics
Price & Volume
Stats
See more52W Range | $0.57-$6.88 |
Market Cap | $110M |
Shares Short | 40M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.46 |
News
See moreYahoo Finance • 11 days ago
Compass Therapeutics Reports 2026 Third Quarter Financial Results and Provides Corporate Update
Yahoo Finance • 14 days ago
Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting
Yahoo Finance • 18 days ago
Compass Therapeutics to Participate in Upcoming November Investor Events
Yahoo Finance • last month
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 39 |